Looking to provide business e-commerce services online to the healthcare
industry, Neoforma.com, Inc. Thursday
purchased fellow healthcare companies Eclipsys Corp. and HEALTHvision Inc. in a stock deal
worth approximately $1.45 billion.
Eclipsys (ECLP), a health care computer service company, will receive 1.344 shares of Neoforma (NEOF) stock, while HEALTHvision, which is affiliated with Eclipsys, will receive 0.444 shares of outstanding Neoforma stock.
Completion of the transactions is expected mid-year, subject to regulatory
and shareholder approvals.
Neoforma is a medical supply e-commerce company, and with the acquisitions
it plans to create a B2B e-healthcare marketplace. Eclipsys provides
software, integration tools, application services provider
information-management
solutions, business process reengineering, network design and
implementation; and full IT outsourcing. HEALTHvision brings to the table
its Web-based healthcare delivery system, connecting physicians, consumers,
patients and the organization’s employees.
Also part of its B2B strategy, Neoforma.com signed an exclusive 10-year
strategic agreement to provide e-commerce services for the 6,500 healthcare
organizations participating in the purchasing programs of Novation, LLC, a
leading buyer of medical supplies and the supply company of national
healthcare alliances VHA Inc. and University HealthSystems Consortium (UHC).
“We are extremely excited to offer an unparalleled array of new e-commerce
services to UHC, VHA and other healthcare customers around the world. From
Web-based clinical solutions to innovative supply-chain initiatives, this
new company’s breadth of offering will be unsurpassed,” said Bob Zollars,
chairman, president and chief executive officer of Neoforma.com. “In
addition, we will combine an ASP model, with net transaction fee revenues,
across a highly recurring revenue base.”
The purchase of Eclipsys comes less than a month after the company made an
unsolicited $2 billion offer for Shared
Medical Systems Corp. (SMS).
Nothing came of the bid.